Latest Hypertension News
Team says the treatment threshold is too high for those over 60 years of age.
After adjustment for multiple variables, PP linked to all outcomes except stroke, cardiovascular death.
Changes in individual lifestyles and how foods are produced are needed to lower consumption.
Research challenges previous findings that suggest ACE inhibitors have greater benefits.
Decrease in age-adjusted death rates from 2000 to 2012; increase from 2012 to 2014.
Online communications reduced need for phone calls and office visits for many.
Renal denervation appears relatively safe and effective, according to recent research.
Sodium restriction linked to increased risk of death or heart failure hospitalization.
Reductions in risks of major CVD events, coronary heart disease, stroke, and heart failure.
Drug found to limit worsening of the disease and reduce the need for hospitalization.
Nitrates reduce activity, quality of life, researchers find.
Analysis of data from the HALT PKD trial showed that 0% to 0.4% of patients experienced potassium levels above 6.5 mEq/L.
The medication significantly decreased potassium levels over 52 weeks in patients with resistant hypertension and diabetic kidney disease.
Hospitalization reported as imminent for 52.8% of patients but observed rate is 31.7%.
Researchers find both common treatments produce modest BP decreases in sleep apnea patients.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)